Literature DB >> 11808942

Neurophysiological evidence of cognitive impairment in patients without hepatic encephalopathy after transjugular intrahepatic portosystemic shunts.

Ludwig Kramer1, Edith Bauer, Alexandra Gendo, Georg Funk, Christian Madl, Johann Pidlich, Alfred Gangl.   

Abstract

OBJECTIVES: We aimed to test the hypothesis that subclinical cognitive brain dysfunction in cirrhotic patients would deteriorate after a transjugular intrahepatic portosystemic shunt (TIPS) in the absence of clinically detectable hepatic encephalopathy.
METHODS: Out of 49 consecutive cirrhotic patients receiving elective TIPS for recurrent variceal hemorrhage, we identified 22 patients who were not encephalopathic and had not undergone liver transplantation at 6-month follow-up and confirmed TIPS patency by Doppler ultrasound. Patients were tested before and 6 months after TIPS implantation using event-related (P300) cognitive evoked potentials, late somatosensory median nerve (N70) potentials, and standard psychometric tests (Mini-Mental State and trailmaking test A). Twenty-two age-matched healthy subjects served as controls.
RESULTS: Relative to controls, patients showed significantly impaired P300 and N70 latencies and abnormal psychometric test results at baseline. Six months after the TIPS, a further impairment of P300 latency was observed (p = 0.005), whereas no relevant changes in N70 latency and psychometric test results occurred.
CONCLUSIONS: In cirrhotic patients with portal hypertension, neurophysiological signs of cognitive brain dysfunction are detectable in the absence of hepatic encephalopathy. A further subclinical deterioration of cognitive processing was observed 6 months after the TIPS. These findings demonstrate an aggravation of subclinical hepatic encephalopathy after a TIPS.

Entities:  

Mesh:

Year:  2002        PMID: 11808942     DOI: 10.1111/j.1572-0241.2002.05441.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  9 in total

Review 1.  Characteristics of minimal hepatic encephalopathy.

Authors:  Piero Amodio; Sara Montagnese; Angelo Gatta; Marsha Y Morgan
Journal:  Metab Brain Dis       Date:  2004-12       Impact factor: 3.584

Review 2.  Neurophysiological investigation of hepatic encephalopathy.

Authors:  Piero Amodio; Angelo Gatta
Journal:  Metab Brain Dis       Date:  2005-12       Impact factor: 3.584

Review 3.  Current and future diagnosis of hepatic encephalopathy.

Authors:  Jasmohan S Bajaj
Journal:  Metab Brain Dis       Date:  2010-03-06       Impact factor: 3.584

Review 4.  Methods for diagnosing hepatic encephalopathy in patients with cirrhosis: a multidimensional approach.

Authors:  Sara Montagnese; Piero Amodio; Marsha Y Morgan
Journal:  Metab Brain Dis       Date:  2004-12       Impact factor: 3.584

5.  Prevalence of subclinical hepatic encephalopathy in cirrhotic patients in China.

Authors:  Yu-Yuan Li; Yu-Qiang Nie; Wei-Hong Sha; Zheng Zeng; Fu-Ying Yang; Li Ping; Lin Jia
Journal:  World J Gastroenterol       Date:  2004-08-15       Impact factor: 5.742

Review 6.  Clinical neurophysiology of hepatic encephalopathy.

Authors:  Piero Amodio; Sara Montagnese
Journal:  J Clin Exp Hepatol       Date:  2014-08-03

7.  Dynamic changes of intrinsic brain activity in cirrhotic patients after transjugular intrahepatic portosystemic shunt: a resting-state FMRI study.

Authors:  Rongfeng Qi; Long Jiang Zhang; Jianhui Zhong; Shengyong Wu; Zhiqiang Zhang; Yuan Zhong; Ling Ni; Gang Zheng; Qing Jiao; Xingjiang Wu; Xinxin Fan; Yijun Liu; Guangming Lu
Journal:  PLoS One       Date:  2012-10-02       Impact factor: 3.240

8.  Cognitive assessment of patients with minimal hepatic encephalopathy in Brazil.

Authors:  D S Torres; J Abrantes; C E Brandão-Mello
Journal:  Metab Brain Dis       Date:  2013-04-28       Impact factor: 3.584

9.  Mini-Mental State Examination in patients with hepatic encephalopathy and liver cirrhosis: a prospective, quantified electroencephalography study.

Authors:  Dorota Koziarska; Ewa Wunsch; Małgorzata Milkiewicz; Maciej Wójcicki; Przemysław Nowacki; Piotr Milkiewicz
Journal:  BMC Gastroenterol       Date:  2013-07-02       Impact factor: 3.067

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.